Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias

Journal of Medicinal Chemistry

Volumn 31, Issue 8, 1988, Pages 1527-1539

  Hollis Showalter, H D ^a   Angelo, Mario M ^a   Berman, Ellen M ^a   Kanter, Gerald D ^a   Ortwine, Daniel F ^a   Ross Kesten, Suzanne G ^a   Sercel, Anthony D ^a   Turner, William R ^a   Werbel, Leslie M ^a   Worth, Donald F ^a   Elslager, Edward F ^a   Leopold, Wilbur R ^a   Shillis, Joan L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIOPYRANO[4,3,2 CD]INDAZOLE DERIVATIVE; DOXORUBICIN; MITOXANTRONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CULTURE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LEUKEMIA L 1210; LEUKEMIA P 388; MELANOMA B16; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMAL; ANTINEOPLASTIC AGENTS; CHEMISTRY; IN VITRO; INDAZOLES; LEUKEMIA L1210; LEUKEMIA P388; MICE; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0023805590     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00403a009     Document Type: Article

References (45)

1. Arcamone, F. Doxorubicin Anticancer Antibiotics; Academic Press: New York, 1981.
2. Wiernik, P. H. In Anthracyclines. Current Status and Development; Crooke, S. T., Reich, S. D., Eds.; Academic: New York, 1980; pp 273-294.
3. Young, R. C.; Ozols, R. F.; Meyers, C. E. N. Engl. J. Med. 1981, 305, 139-153.
4. Formelli, F.; Casazza, A. M. Drugs Expt. Clin. Res. 1984, 10, 75-84.
5. Arcamone, F. Tumori 1984, 70, 113-119.
6. Arcamone, F. Cancer Res. 1985, 45, 5995-5999.
7. Showalter, H. D. H.; Fry, D. W.; Leopold, W. R.; Lown, J. W.; Plambeck, J. A.; Reszka, K. Anti-Cancer Drug Des. 1986, 1, 73-85.
8. Showalter, H. D. H.; Jonhson, J. L.; Hoftiezer, J. M.; Turner, W. R.; Werbel, L. M.; Leopold, W. R.; Shillis, J. L.; Jackson, R. C.; Elslager, E. F. J. Med. Chem. 1987,30,121-131.
9. Showalter, H. D. H.; Johnson, J. L.; Hoftiezer, J. M. J. Heterocycl. Chem. 1986, 23, 1491-1501.
10. Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Cancer Res. 1985, 45, 5532-5539.
11. Klohs, W. D.; Steinkampf, R. W.; Havlick, M. J.; Jackson, R. C. Cancer Res. 1986, 46, 4352-4356.
12. Showalter, H. D. H.; Werbel, L. M.; Leopold, W. R.; Fry, D. W.; Klohs, W. D.; Jackson, R. C. In Anthracycline and Anthracenedione-Based Anticancer Agents; Lown, J. W. Ed.; Elsevier: Amsterdam, in press.
13. Fry, D. W.; Boritzki, T. J.; Besserer, J. A.; Jackson, R. C. Biochem. Pharmacol. 1985, 34, 3499-3508.
14. White, R. J.; Durr, F. E. Invest. New Drugs 1985, 3, 85-93.
15. Alberts, D. S.; Peng, Y. M.; Bowden, G. T.; Dalton, W. S.; Mackel, C. Invest. New Drugs. 1985, 3,101-107.
16. Cheng, C. G.; Zee-Cheng, R. K. Y. Prog. Med. Chem. 1983, 20, 83-118.
17. Werbel, L. M.; Elslager, E. F.; Fry, D. W.; Jackson, R. G.; Leopold, W. R.; Showalter, H. D. H. In New Avenues in Developmental Cancer Chemotherapy; Harrap, K. R., Connors, T. A., Eds; Academic: New York, 1987; Vol. 8, pp 355-365.
18. Werbel, L. M.; Elslager, E. F.; Ortwine, D. F.; Shillis, J. L.; Showalter, H. D. H.; Worth, D. F.; Plowman, J. Proc. Am. Assoc. Cancer Res. 1985, 26, 254.
19. Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Plowman, J. Proc. Am. Assoc. Cancer Res. 1985, 26, 253.
20. Fry, D. W.; Besserer, J. A. Mol. Pharmacol. 1988, 33, 84-92.
21. Elslager, E. F.; Worth, D. F.; Howells, J. D. U.S. Pat. 3505341, 1970.
22. Elslager, E. F.; Worth, D. F.; Howells, J. D. U.S. Pat. 3505341, 1970; Chem. Abstr. 1969, 71, 124442.
23. Hirschberg, E. Antibiotics; Gottlieb, D., Shaw, P. D., Corcoran, J. W., Eds; Springer: New York, 1975; Vol. III, pp 274-303.
24. Rosi, D.; Perruzzotti, G.; Dennis, E. W.; Berberian, D. A.; Freele, H.; Archer, S. J. Med. Chem. 1967, 10, 867-876.
25. Wong, C.-M.; Mi, A.-Q.; Haque, W.; Lam, H.-Y.; Marat, K. Can. J. Chem. 1984, 62, 1600-1607.
26. Wong, C.-M.; Mi, A.-Q.; Ren, J.; Haque, W.; Marat, K. Tetrahedron 1984, 40, 4789-4793.
27. Arnold, H.; Pahls, K.; Potsch, D. Tetrahedron Lett. 1969, 137-139.
28. Goulding, B. T.; Hall, D. R. J. Chem. Soc., Perkin Trans. 1 1975, 1302-8.
29. Cabré, J.; Palomo, A. L. Synthesis 1984, 413-417.
30. Engelhardt, E. L.; Remy, D. C. U.S. Pat. 3697544,1972.
31. Engelhardt, E. L.; Remy, D. C. Chem. Abstr. 1973, 78, 16249.
32. Bennett, O. F.; Johnson, J.; Tramondozzi, J. Org. Prep. Proced. Int. 1974, 6, 287-293.
33. Bannerjee, P. K.; Chaudhury, D. N. J. Indian Chem. Soc. 1959, 36, 257-259.
34. Graebe, C.; Schultefs, O. Ann. Chem. 1891, 263, 1-15.
35. Bourdais, J. Fr. Pat. 1443917, 1966.
36. Bourdais, J. Chem. Abstr. 1967, 66, 37933.
37. Lehmstedt, K.; Schrader, K. Chem. Ber. 1937, 70B, 1526-1538.
38. Sindelar, K.; Kakac, B.; Svatek, E.; Holubek, J.; Metysova, J.; Hrubantova, M.; Protiva, M. Collect. Czech. Chem. Commun. 1973, 38, 3321-3338.
39. Baguley, B. C.; Nash, R. Eur. J. Cancer 1981, 17, 671-679.
40. Geran, R. I.; Greenberg, N. H.; MacDonald, M. M.; Schumacher,A. M.; Abbott, B. J. Cancer Cemother. Rep., Part 3 1972, 3, 1-85.
41. Berman, E.; Klohs, W.; Leopold, W. R.; Plowman, J.; Sercel,A. D.; Shillis, J. L.; Showalter, H. D. H.; Werbel, L. M. Proc.Am. Assoc. Cancer Res. 1987, 28, 302.
42. Schabel, F. M., Jr.; Griswold, D. P., Jr.; Laster, W. R., Jr.;Corbett, T. H.; Lloyd, H. H. Pharmacol. Ther., Part A 1977,1, 411-435.
43. Archer, S.; Suter, C. M. J. Am. Chem. Soc. 1952, 74,4296-4309.
44. Elslager, E. F.; Weistein, E. A.; Worth, D. F. J. Med. Chem. 1964, 7, 493-500.
45. Archer, S.; Miller, K. J.; Rej, R.; Periana, C.; Pricker, L. J. Med. Chem. 1982, 25, 220-227.